Cargando…
Potential for Improving Potency and Specificity of Reovirus Oncolysis with Next-Generation Reovirus Variants
Viruses that specifically replicate in tumor over normal cells offer promising cancer therapies. Oncolytic viruses (OV) not only kill the tumor cells directly; they also promote anti-tumor immunotherapeutic responses. Other major advantages of OVs are that they dose-escalate in tumors and can be gen...
Autores principales: | Mohamed, Adil, Johnston, Randal N., Shmulevitz, Maya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690860/ https://www.ncbi.nlm.nih.gov/pubmed/26633466 http://dx.doi.org/10.3390/v7122936 |
Ejemplares similares
-
Activation of p53 by Chemotherapeutic Agents Enhances Reovirus Oncolysis
por: Pan, Da, et al.
Publicado: (2013) -
Current understanding of reovirus oncolysis mechanisms
por: Phillips, Matthew B, et al.
Publicado: (2018) -
Attenuated reovirus displays oncolysis with reduced host toxicity
por: Kim, M, et al.
Publicado: (2011) -
Proteolytic Disassembly Is a Critical Determinant for Reovirus Oncolysis
por: Alain, Tommy, et al.
Publicado: (2007) -
Activated Ras Signaling Pathways and Reovirus Oncolysis: An Update on the Mechanism of Preferential Reovirus Replication in Cancer Cells
por: Gong, Jun, et al.
Publicado: (2014)